BioNexus Gene Lab Corp
NASDAQ:BGLC
Profitability Summary
BioNexus Gene Lab Corp's profitability score is hidden . We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.
Profitability Score
We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.
We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.
Profitability Score
Margins
Earnings Waterfall
BioNexus Gene Lab Corp
Margins Comparison
BioNexus Gene Lab Corp Competitors
| Country | Company | Market Cap |
Gross Margin |
Operating Margin |
Net Margin |
||
|---|---|---|---|---|---|---|---|
| MY |
|
BioNexus Gene Lab Corp
NASDAQ:BGLC
|
3.5m USD |
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
197B USD |
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
43B EUR |
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
|
42.5B USD |
Loading...
|
Loading...
|
Loading...
|
|
| CN |
|
WuXi AppTec Co Ltd
SSE:603259
|
289.9B CNY |
Loading...
|
Loading...
|
Loading...
|
|
| DE |
|
BioNTech SE
NASDAQ:BNTX
|
26.2B USD |
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
United Therapeutics Corp
NASDAQ:UTHR
|
20.3B USD |
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Incyte Corp
NASDAQ:INCY
|
19.4B USD |
Loading...
|
Loading...
|
Loading...
|
|
| BM |
|
Roivant Sciences Ltd
NASDAQ:ROIV
|
18.6B USD |
Loading...
|
Loading...
|
Loading...
|
|
| DK |
|
Genmab A/S
CSE:GMAB
|
117.9B DKK |
Loading...
|
Loading...
|
Loading...
|
Return on Capital
Return on Capital Comparison
BioNexus Gene Lab Corp Competitors
| Country | Company | Market Cap | ROE | ROA | ROCE | ROIC | ||
|---|---|---|---|---|---|---|---|---|
| MY |
|
BioNexus Gene Lab Corp
NASDAQ:BGLC
|
3.5m USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
197B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
43B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
|
42.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CN |
|
WuXi AppTec Co Ltd
SSE:603259
|
289.9B CNY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| DE |
|
BioNTech SE
NASDAQ:BNTX
|
26.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
United Therapeutics Corp
NASDAQ:UTHR
|
20.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Incyte Corp
NASDAQ:INCY
|
19.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| BM |
|
Roivant Sciences Ltd
NASDAQ:ROIV
|
18.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| DK |
|
Genmab A/S
CSE:GMAB
|
117.9B DKK |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
